Skip to main content
. 2018 Jun 1;31(3):162–169. doi: 10.1089/jamp.2017.1384

Table 4.

Assay and Related Substances Results for Glycopyrrolate Pre- and Postnebulization Test Samples

      Postnebulized (n = 3, mean ± SD)
Glycopyrrolate strength Drug assay/related substances Prenebulized Nebulizer 1 Nebulizer 2
25 μg/mL Active (% nominal concentration) 98.70 98.64 ± 0.32 98.69 ± 0.15
Known impurity 1 (%) 0.15 0.15 ± 0.01 0.14 ± 0.00
Known impurity 2 (%) 0.28 0.29 ± 0.01 0.28 ± 0.00
Largest unknown impurity (%) 0.36 0.33 ± 0.02 0.34 ± 0.02
Total impurities (%) 0.78 0.77 ± 0.02 0.76 ± 0.01
50 μg/mL Active (% nominal concentration) 98.70 98.31 ± 0.33 98.76 ± 0.78
Known impurity 1 (%) <0.10 <0.10 <0.10
Known impurity 2 (%) 0.23 0.24 ± 0.00 0.24 ± 0.00
Largest unknown impurity (%) 0.14 0.14 ± 0.01 0.14 ± 0.01
Total impurities (%) 0.38 0.38 ± 0.01 0.38 ± 0.01

SD, standard deviation.